Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis
March 11, 2024 updated by: Sharon Jones, Marshall University
At this time, Saint Mary's Medical Center is currently in the process of implementing a standardized diabetic ketoacidosis (DKA) protocol.
The first main goal of this project will be to evaluate patient outcomes to determine the effects of treating patients without a standardized protocol and to establish a baseline on how patients are being treating with DKA.
The final goal of the project will be to compare outcomes of those patients not placed on the protocol to those that were treated using SMMC newly implemented DKA protocol.
The overall goal of this project is to determine the benefit of an institutional DKA protocol.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Virginia
-
Huntington, West Virginia, United States, 25702
- St. Mary's Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Those patients admitted to St. Mary's Medical Center with a diagnosis of DKA.
Description
Inclusion Criteria:
- Admitted to St. Mary's Medical Center with DKA
- >/= 18 years of age
Exclusion Criteria:
- < 18 years of age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
2
Patients treated for DKA under DKA protocol implemented by hospital
|
|
1
To establish a baseline on how patients are being treating with DKA in general and without a standardized DKA protocol
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Hospital length of stay
Time Frame: Time in hospital
|
Time in hospital
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
ICU length of stay
Time Frame: hospital stay
|
hospital stay
|
|
ICU length of stay Hypoglycemic events (BG<60)
Time Frame: hospital stay
|
hospital stay
|
|
Time to correction of glucose level and anion gap
Time Frame: hospital stay
|
hospital stay
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sharon Jones, Pharm.D., St. Mary's Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2007
Primary Completion (Actual)
July 1, 2008
Study Completion (Actual)
July 1, 2008
Study Registration Dates
First Submitted
December 26, 2007
First Submitted That Met QC Criteria
January 9, 2008
First Posted (Estimated)
January 10, 2008
Study Record Updates
Last Update Posted (Actual)
March 13, 2024
Last Update Submitted That Met QC Criteria
March 11, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9137
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.